about
A model of ischemia-induced neuroblast activation in the adult subventricular zoneP2X3 receptor localizes into lipid rafts in neuronal cellsPlasticity of primary microglia on micropatterned geometries and spontaneous long-distance migration in microfluidic channels.Role of the metabotropic P2Y(4) receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor.Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development.Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue.Extracellular ATP and nerve growth factor intensify hypoglycemia-induced cell death in primary neurons: role of P2 and NGFRp75 receptors.Synaptic P2X7 and oxygen/glucose deprivation in organotypic hippocampal cultures.Extracellular adenosine triphosphate induces glutamate transporter-1 expression in hippocampus.P2Y1 receptor switches to neurons from glia in juvenile versus neonatal rat cerebellar cortex.Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosisThe metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells.Extracellular ATP and neurodegeneration.P2 receptor web: complexity and fine-tuning.The role of ionotropic purinergic receptors (P2X) in mediating plasticity responses in the central nervous system.Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.Receptor webs: can the chunking theory tell us more about it?Protein cooperation: from neurons to networks.M1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b.Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.ALS: focus on purinergic signalling.Purinergic signalling: what is missing and needed next? The use of transgenic mice, crystallographic analysis and MicroRNA.P2X7 receptors: channels, pores and more.Metabotropic purinergic receptors in lipid membrane microdomains.MicroRNAs: newcomers into the ALS picture.Purinergic contribution to amyotrophic lateral sclerosis.UDP exerts cytostatic and cytotoxic actions in human neuroblastoma SH-SY5Y cells over-expressing P2Y6 receptor.The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis.Rapid constitutive and ligand-activated endocytic trafficking of P2X receptor.Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: An immunohistological study.P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death.Pathways of survival induced by NGF and extracellular ATP after growth factor deprivation.Overexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: effect of estrogen and copper chelators.The P2Y₄ receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells.Antagonists of P2 receptor prevent NGF-dependent neuritogenesis in PC12 cells.P2X7 Receptor Activation Modulates Autophagy in SOD1-G93A Mouse Microglia.Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation.P2Y(12) receptor on the verge of a neuroinflammatory breakdownEffects of acute perinatal asphyxia in the rat hippocampus.P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis.
P50
Q27349769-3E03E9BC-8CC0-47A6-81B5-E835A619189EQ28572892-F8451868-5CCC-41EA-9742-9F5C819D3F68Q30558808-4A04E756-CD28-44D6-9EED-E71FAC275691Q30841109-F3E55DDB-5EEF-4911-9F60-32E57F99D4B0Q31142299-B763CD2A-11F6-4401-8F3A-C59FB45E5992Q31637587-0B66A986-C202-4FF0-9BB0-5B3533ADB9E9Q33185189-D628A922-DE74-494B-9392-382E08E410EFQ33201682-4A88F5DF-BF90-4D37-BC95-FFD297827C3DQ33276190-05E3C734-7B7C-43B6-B0B5-42AE6042BC69Q33289232-2252A07A-2E9C-4503-B561-755460CC93FCQ34081777-8C21E625-350B-4B29-B4DF-A894D240ED56Q34384215-418105EB-2FBE-40CC-A7C2-801B4A2D4C4EQ35610626-92EBF0D1-F0BE-4809-9F46-FEA2248E8696Q36509424-64A1EF1C-2D85-4A87-A79F-26E1FB620B76Q36586757-8D216F16-72E0-4D2F-B1C3-CF1F331E7E0EQ37196234-D01C8401-1306-4A79-A38C-CA3088688F6AQ37206080-8FCACB24-FE43-4BB4-8D3C-0D5D3E145E0BQ37250266-47251A0D-2543-443D-B509-9248C7E9F585Q37549540-496F14A9-DFED-484A-B0EB-5A45C67C29B6Q37826775-8DB65DDD-DA88-460E-BB83-CD671A6B27E4Q37894292-FA23A9D0-C922-4476-B1E9-07DBBCF1D59AQ38042106-6BA0BB2A-DAA4-4068-8B92-9A1354DD8B5EQ38042107-09DFFC00-98BD-42CE-AC94-ED08B43D500FQ38059726-E4636F83-0456-4387-988B-5638EC6226FAQ38329174-8C014CEC-95AE-4092-9C51-6D4DD0DEC0B4Q38619540-0C558807-EA66-42AC-B171-50D95C91422AQ39741722-04F95038-3CF3-462D-A5C2-6313CF1F5248Q39802891-03A01C99-ABB8-473B-A808-D7AE5A4F2620Q39839310-785D9AA9-9518-4ED3-A0F9-132C44C64D72Q39959387-11AF729F-449E-4C85-B2D2-DE1A940AA00EQ40359371-0C81524E-D096-43A7-98C1-168831D53DB4Q40603053-4DCB6231-166B-4CC9-BCF3-FDE90477B581Q40636463-BB4D5C02-5D3C-4D22-B814-EFDA8275D17EQ40726653-5D94D8F2-2DAD-4B8F-8A5E-5B0EC9AB6125Q40892261-5A50EF80-E20D-456E-B523-798FBCFF93F9Q41484919-559D65A3-C103-4DC5-9C13-D4A50B34EEBBQ41844725-29E20AC3-4DC2-4E36-B848-069B400B8FA3Q42077163-0D4DC424-A736-4D33-9857-74F80A651AEDQ43184917-7E1AE634-EFEB-4FE3-A082-2A275C906EEAQ43270590-823F090E-5202-49DB-B0AC-FC5CBD09C5E9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cinzia Volonté
@ast
Cinzia Volonté
@en
Cinzia Volonté
@es
Cinzia Volonté
@nl
Cinzia Volonté
@sl
type
label
Cinzia Volonté
@ast
Cinzia Volonté
@en
Cinzia Volonté
@es
Cinzia Volonté
@nl
Cinzia Volonté
@sl
altLabel
Cinzia Volonte
@en
prefLabel
Cinzia Volonté
@ast
Cinzia Volonté
@en
Cinzia Volonté
@es
Cinzia Volonté
@nl
Cinzia Volonté
@sl
P108
P1053
N-6474-2013
P106
P108
P1153
7006874326
P21
P2798
P31
P3829
P496
0000-0001-7362-8307